[Ventricular arrhythmias: diagnosis and drug therapy].
After a brief classification of antiarrhythmic drugs and their mode of action, ventricular dysrhythmias are defined and characterized with respect to underlying causes. A short chapter is dedicated to the treatment of acute ventricular tachycardia, a longer one to the prophylaxis of ventricular dysrhythmias, based on our knowledge in the "post CAST Study era' (CAST = Cardiac Arrhythmia Suppression Trial). A special interest is dedicated to patients commonly encountered in daily practise: patients with coronary artery disease, patients with chronic heart failure, and patients without underlying heart disease. Then a separate assessment is made of the proarrhythmic effects of antiarrhythmic drugs.
Schüpfer
C
C
Abteilung für Kardiologie, Department Medizin, Universitätsklinik Bern.
Gertsch
M
M
D000889:Anti-Arrhythmia Agents / Q000145:classification / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000175:diagnosis* / Q000188:drug therapy* / Q000503:physiopathology; D002986:Clinical Trials as Topic; D004562:Electrocardiography; D006352:Heart Ventricles / Q000503:physiopathology; D006801:Humans; D009203:Myocardial Infarction / Q000503:physiopathology; D017180:Tachycardia, Ventricular / Q000188:drug therapy / Q000503:physiopathology
D000889:Anti-Arrhythmia Agents
Ventrikuläre Rhythmusstörungen: Diagnostik und medikamentöse Therapie.